From regulatory hypotheses to research decisions

Gene Regulatory Network Analysis

Identify candidate regulators, compare cell-state programs, and connect omics evidence to the next experiment. CD ComputaBio helps turn gene expression and supporting data into interpretable regulatory hypotheses.

Regulator prioritization Regulon analysis Validation planning

Share your species, data type, study design, and research question for initial project feedback within 24 hours.

The essential answer

What Is a Gene Regulatory Network?

A gene regulatory network describes how regulators, such as transcription factors, influence gene expression. Computational GRN analysis infers candidate regulatory relationships from expression data and supporting evidence. These relationships generate testable hypotheses; they do not automatically establish direct binding or causality.

In a transcription-factor-centered network, nodes represent regulators and candidate target genes, while edges describe inferred or supported relationships. A regulon groups a regulator with its candidate targets. Its activity can summarize a regulatory program, but the meaning of each score depends on the inference and scoring method.

Our bioinformatics analysis services connect network construction with biological interpretation, reproducibility checks, and a clear next-step decision.

Schematic gene regulatory network with orange regulator nodes linked to blue candidate target genes
Schematic illustration of regulators and candidate targets; not experimental results.

Different networks, different conclusions

GRN vs. Co-Expression Network: What Is the Difference?

Genes can change together without directly regulating each other. Distinguishing association from a directional regulatory hypothesis is essential when interpreting network diagrams and selecting experiments.

Network or Evidence Main Question Interpretation Boundary
Co-expression network Which genes show coordinated expression across samples or cells? Correlation does not identify a regulator, a direct interaction, or a causal direction.
Inferred regulatory network Which regulators may be linked to which target genes in this context? Direction and sign depend on the method; inferred edges remain hypotheses.
Experimentally supported relationship Which candidate relationships have relevant binding or perturbation evidence? Binding does not alone prove a functional effect, and evidence may be context-specific.

Weighted co-expression modules can help organize expression patterns. They should not be relabeled as confirmed regulatory circuitry. Likewise, network centrality measures connectivity; it is not proof that a hub is a causal driver or a tractable drug target.

Start with a decision

What Can You Learn from Your Data?

01 / REGULATORS

Which regulators merit attention?

Prioritize transcription factors using target support, activity patterns, stability, and relevant prior evidence.

02 / STATES

Which programs differ?

Compare regulatory activity across conditions or cell states while accounting for the biological replication structure.

03 / MODULES

What do modules suggest?

Connect candidate target sets with pathways and phenotypes, distinguishing enrichment from a demonstrated mechanism.

04 / EXPERIMENTS

What should be tested next?

Select focused regulator–target hypotheses for perturbation, binding, reporter, or phenotype experiments.

Data-matched inference

Which Analysis Fits Your Dataset?

The analysis is selected around your study design, reference resources, and intended comparison. Human and mouse projects are common starting points; other species require an annotation and motif-resource review.

BULK TRANSCRIPTOMICS

Bulk RNA-Seq or Expression Matrices

Use sample-level expression to study coordinated programs and candidate regulator relationships. Provide counts or abundance values with processing history, gene identifiers, group labels, and covariates.

  • Review sample size, batch–group confounding, and tissue composition.
  • Choose association or TF-centered inference according to the evidence available.
  • For downstream candidates, consider target discovery from RNA-seq data analysis.
SINGLE-CELL TRANSCRIPTOMICS

Single-Cell or Single-Nucleus RNA-Seq

Evaluate cell-type-associated regulons and activity patterns using annotated expression data, subject identifiers, and QC records. SCENIC-style approaches combine expression-based candidates with motif support. 1

  • Account for sparsity, cell selection, and annotation uncertainty.
  • Distinguish cells from independent biological replicates.
  • Assess whether cell-type composition explains a condition-associated signal.
CHROMATIN + EXPRESSION

RNA and ATAC Multiomics

Combine expression, chromatin accessibility, and motif information to investigate candidate TF–region–gene links. Jointly profiled RNA expression and chromatin accessibility data require different integration assumptions from separately generated datasets.

  • Record genome build, peak coordinates, and sample correspondence.
  • Review peak-to-gene linkage and motif-family ambiguity.
  • Use enhancer support to refine hypotheses, not to claim universal direct regulation.
DYNAMICS + PERTURBATION

Time-Series or Perturbation Data

Use measured time points or controlled interventions to examine regulatory responses. Share the sampling schedule, treatment or perturbation, controls, and biological replicates.

  • Separate measured time from inferred pseudotime.
  • Consider secondary responses and viability effects.
  • Define which conclusions the experimental design can support.

Useful information for the initial review

Species & tissue Sample / donor IDs Groups & endpoint Data format Batch & covariates Existing validation

Two downstream paths

From Regulatory Networks to Research Candidates

A network can support different decisions. Biomarker studies ask whether a feature helps measure or predict a defined outcome. Target studies ask whether an intervention hypothesis merits functional testing. The evidence and validation requirements differ.

Measure or predict a state Regulatory features → candidate signature → independent evaluation
Investigate an intervention point Candidate regulator → convergent evidence → perturbation study

Biomarker pathway

Can Regulatory Networks Help Identify Biomarkers?

Move from a regulatory feature to a defined context of use.

Regulon activity or network-derived features may provide candidate markers for disease classification, prognosis, or treatment response. Their value depends on reproducibility, the chosen endpoint, and performance beyond the data used to discover them.

Our biomarker discovery from omics data service extends candidate selection into endpoint-defined signature development and validation planning. When prediction is involved, feature selection and data-dependent network construction must be contained within training or resampling boundaries to avoid leakage.

Target pathway

How Can GRN Analysis Support Target Discovery?

Move from a connected regulator to a testable intervention hypothesis.

Regulator candidates can be prioritized by state specificity, consistent target support, robustness, and existing functional evidence. High degree or differential expression alone does not establish therapeutic relevance.

Our target discovery from omics data service places network findings alongside disease relevance, complementary molecular layers, and available perturbation evidence. Causality, druggability, and safety require further assessment; they are not implied by a network rank.

Traceable analysis

Analysis Workflow & Quality Checks

01

Define the question

Specify biological context, comparison, endpoint, unit of replication, and the decision the network should support.

Decision output Project scope and analysis plan.
02

Audit data and metadata

Review quality, identifiers, sample relationships, missingness, covariates, and confounding before selecting an inference strategy.

Decision output Usable data, limitations, and information gaps.
03

Prepare the reference

Harmonize gene IDs and relevant genome, motif, and prior-network resources; document exclusions and preprocessing.

Decision output Versioned analysis inputs.
04

Infer and score

Construct candidate relationships or regulons and estimate activity using methods appropriate to the available data.

Decision output Candidate edge tables and activity results.
05

Evaluate robustness

Inspect resampling or repeated-run stability, threshold sensitivity, and relevant external evidence. Compare groups using the study design.

Decision output Supported priorities and uncertainty notes.
06

Interpret and plan validation

Explain candidate programs, summarize evidence, and define experiments that could discriminate between regulatory hypotheses.

Decision output Prioritized hypotheses and validation plan.

Where applicable, comparisons report effect sizes, uncertainty, and multiplicity-adjusted significance. A larger number of cells cannot resolve a lack of donor-level replication, and an algorithm cannot reliably separate biology from a completely confounded batch design.

Beyond a network picture

What You Receive

Data & Design Review

QC findings, sample structure, exclusions, important covariates, and limits on the proposed inference.

Candidate Edge Tables

Regulator, target, method-specific score, evidence source, context, and support annotations where available.

Regulons & Activity Results

Candidate target sets and activity matrices, with definitions, scoring conventions, and interpretation notes.

Condition or State Comparisons

Design-aware results for selected contrasts, including effect estimates and relevant uncertainty.

Regulator Evidence Cards

A focused shortlist explaining ranking components, biological context, disagreements, and proposed tests.

Figures & Technical Report

Readable local networks, summary plots, methods and version records, and an actionable validation strategy.

What makes an edge interpretable?

An edge should retain its context and evidence. The illustrative record below explains the fields; it is not a client result or a measured regulatory relationship.

Regulator Target Score Evidence Type Context Limitation
Candidate TF Candidate gene Method-specific importance Expression inference + motif support Defined cell type / condition Direct regulation remains unconfirmed

Published method evidence

Combining Expression with Regulatory Evidence

SCENIC links expression-based candidate relationships with motif information, while SCENIC+ incorporates chromatin accessibility to infer enhancer-associated regulatory networks. 1, 2 These are method examples, not a fixed pipeline for every dataset. Figure 1 from the SCENIC+ study illustrates how expression, accessible regions, and motifs contribute different evidence.

Published SCENIC+ Figure 1 showing the multiomic workflow, motif collection, and method evaluation panels
Integration of chromatin accessibility, transcription factor motifs, and gene expression in an enhancer-driven regulatory inference workflow. 2

This published figure explains a specific method and its evaluation. It does not establish the accuracy of a client network. For each project, we assess resource coverage, data compatibility, and whether the inferred relationships are stable enough to support the intended next step.

Separate evidence levels

Label expression-based, motif-supported, binding-supported, and perturbation-supported relationships. Scores from different methods are not automatically comparable.

Review stability

Check whether important candidates persist under reasonable analysis choices. A visually dense graph is not evidence of stronger biological support.

Design a discriminating test

Match the experiment to the claim: binding assays for occupancy, perturbation for response, and functional assays for the phenotype of interest.

Practical project questions

Frequently Asked Questions

How many samples are needed for GRN analysis?

There is no universal minimum. Feasibility depends on biological variability, the number of features, replication, data quality, and the intended comparison. Small datasets may support exploratory or prior-guided interpretation while limiting de novo inference and generalization.

Can I start with a differential gene list?

A gene list can support enrichment or prior-network interpretation, but it does not contain the sample-level variation needed for expression-based network inference. Share the expression matrix and metadata if available; otherwise, the scope should explicitly reflect the missing information.

Does an inferred edge prove direct regulation?

No. Edges depend on the inputs and model assumptions. Motif support can strengthen a regulatory hypothesis, but direct binding and functional consequences require relevant experiments.

Can existing processed data be used?

Yes, after review. Counts, abundance matrices, AnnData/Seurat objects, and chromatin feature tables may be suitable. Provide processing history, species, reference versions, identifiers, sample or donor labels, and the biological comparison.

Do you provide free GRN software?

This page describes a custom analysis service. Public tools are cited to explain possible methods; the project is scoped around data review, analysis, interpretation, and agreed deliverables.

What affects cost and turnaround?

Dataset size, modalities, required preprocessing, species resources, contrasts, and robustness checks determine the scope. Initial feedback is provided within 24 hours; formal quotation and analysis timelines are confirmed after technical review.

Your next step

Turn Your Dataset into a Focused Analysis Plan

Send a brief summary of your species, tissue or cell system, data type, sample and donor counts, study groups, and intended outcome. We will provide initial feedback within 24 hours on the information available and the appropriate starting scope.

For files or a data-accession reference, email business@computabio.com. For confidential data, agree on transfer arrangements before sharing files. Detailed proposals and study execution have separate timelines.

Request a GRN Project Review

Scientific References

  1. Aibar, S.; González-Blas, C. B.; Moerman, T.; et al. SCENIC: single-cell regulatory network inference and clustering. Nature Methods 2017, 14, 1083–1086. https://doi.org/10.1038/nmeth.4463. Official SCENIC documentation.
  2. Bravo González-Blas, C.; De Winter, S.; Hulselmans, G.; et al. SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks. Nature Methods 2023, 20, 1355–1367. https://doi.org/10.1038/s41592-023-01938-4. Figure 1 distributed under Creative Commons Attribution 4.0 International (CC BY 4.0).

Online Inquiry

Submit your project details below, and our team will respond within 24 hours.

x
Need help getting the data you need?

Talk to our technical team about your project!

I Want To Talk